Adello Biologics names Amneal co-chairman as CEO

BY Antoinette Alexander

Adello Biologics, a U.S.-based biotechnology company headquartered in Piscataway, N.J., has named Chintu Patel as CEO, effective immediately. Patel succeeds Peter Moesta, who is stepping down to pursue other opportunities.

Most recently co-CEO, co-chairman and co-founder of generic pharmaceutical company Amneal Pharmaceuticals, Patel is now a co-chairman of the Amneal board of directors.

“I am delighted to lead a team of distinguished scientists and professionals at Adello,” said Patel. “Together, we will harness the extraordinary potential of the biosimilars market and transform Adello into a world-class healthcare company that develops important, affordable, accessible medical treatments. I would like to thank Peter for his contributions to advancing Adello’s lead biosimilar candidates towards registration. I wish him the best of luck in his new endeavors.”

Patel has more than 20 years of experience within the industry, beginning with his career at Eckerd Pharmacy. He has been recognized by his peers on numerous occasions, including the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award. He has been a featured speaker at the Hauppauge Industrial Association of New York and serves on the boards of the Long Island Association and the Make-a-Wish Foundation. With his wife, Falguni, Patel created the Irada Foundation, focused on health and education issues.

He holds a Bachelor’s degree in pharmacy from Rutgers College of Pharmacy and an honorary Doctor of Science from Long Island University.


Leave a Reply

No comments found



What area is your company focused most on in 2019?
  • Add your answer